Santhera, European Vision Institute Clinical Research Network deal

The network will provide Santhera with data from patients with Leber's hereditary optic neuropathy (LHON) from centers within the institute's network for inclusion in a revised MAA for Santhera's Raxone idebenone. Data from the independent network, which includes 76 ophthalmological clinical research sites in 16 European countries, will include the change in vision over time in untreated LHON patients. Santhera plans to use the data as a comparator group with the company's own vision outcomes data in the revised MAA. The institute declined to disclose details, and Santhera could not be reached. ...